Get 40% Off
💰 Warren Buffett reveals a $6.72 billion stake in ChubbCopy Portfolios

U.S. FDA advisers back Moderna COVID-19 vaccine for small children

Published 06/15/2022, 03:49 PM
Updated 06/15/2022, 03:51 PM
© Reuters. FILE PHOTO: Moderna's logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic
MRNA
-

(Reuters) - U.S. Food and Drug Administration advisers on Wednesday recommended the authorization of Moderna (NASDAQ:MRNA) Inc's COVID-19 vaccine for children aged 6 months through 5 years, an important step toward immunizing millions children who have been ineligible for the shots during the pandemic.

The same panel of outside experts is expected to vote within an hour on whether or not to recommend the Pfizer-BioNTech vaccine for children aged 6 months through 4 years old.

Latest comments

.00000000001% risk. Makes sense
Yeah...what a shame those children under 5 years old are the most at risk patients for COVID. There is just, oh, soooooo much data out there to support this claim. Daycares are practically death camps. /s
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.